Employing Real-World Evidence for the Economic Evaluation of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation in Thailand

R Krittayaphong, U Permsuwan - Applied Health Economics and Health …, 2024 - Springer
Background This study aimed to assess the cost-effectiveness of non-vitamin K antagonist
oral anticoagulants (NOACs) in comparison with warfarin using data from real practice …
相关文章

Employing Real-World Evidence for the Economic Evaluation of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation in Thailand

R Krittayaphong, U Permsuwan - Applied health economics and … - pubmed.ncbi.nlm.nih.gov
Background This study aimed to assess the cost-effectiveness of non-vitamin K antagonist
oral anticoagulants (NOACs) in comparison with warfarin using data from real practice …

Employing Real-World Evidence for the Economic Evaluation of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation in Thailand.

R Krittayaphong, U Permsuwan - Applied Health Economics and …, 2024 - europepmc.org
Background This study aimed to assess the cost-effectiveness of non-vitamin K antagonist
oral anticoagulants (NOACs) in comparison with warfarin using data from real practice …